Transcriptional adaptation upregulates utrophin in Duchenne muscular dystrophy – Nature
Blake, D. J., Weir, A., Newey, S. E. & Davies, K. E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291–329 (2002).
Google Scholar
Duan, D., Goemans, N., Takeda, S., Mercuri, E. & Aartsma-Ru, A. Duchenne muscular dystrophy. Nat. Rev. Dis. Primers. 7, 13 (2021).
Google Scholar
Helliwell, T. R., Man, N. T., Morris, G. E. & Davies, K. E. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal-muscle fibers in dystrophies and inflammatory myopathies. Neuromuscul. Disord. 2, 177–184 (1992).
Google Scholar
Anthony, K. et al. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping. JAMA Neurol. 71, 32–40 (2014).
Google Scholar
Guiraud, S. & Davies, K. Utrophin correlates with disease severity in Duchenne muscular dystrophy. Med. 4, 220–222 (2023).
Google Scholar
Rossi, A. et al. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature 524, 230–233 (2015).
Google Scholar
El-Brolosy, M. A. & Stainier, D. Y. R. Genetic compensation: a phenomenon in search of mechanisms. PLoS Genet. 13, e1006780 (2017).
Google Scholar
El-Brolosy, M. A. et al. Genetic compensation triggered by mutant mRNA degradation. Nature 568, 193–197 (2019).
Google Scholar
Mendell, J. R. et al. Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann. Neurol. 74, 637–647 (2013).
Google Scholar
Bushby, K. et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve 50, 477–487 (2014).
Google Scholar
Duan, D., Luo, J. & Zhang, Y. AAV-mediated micro-dystrophin gene therapy in dystrophin-deficient mice. Mol. Ther. 26, 2975–2986 (2018).
Google Scholar
Deconinck, A. E. et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90, 717–727 (1997).
Google Scholar
Law, D. J., Allen, D. L. & Tidball, J. G. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J. Cell Sci. 107, 1477–1483 (1994).
Google Scholar
Georgieva, A. M. et al. Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression. Nat. Commun. 13, 4184 (2022).
Google Scholar
Janghra, N. et al. Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in Duchenne and Becker muscular dystrophy muscle biopsies. PLoS ONE 11, e0150818 (2016).
Google Scholar
Kleopa, K. A., Drousiotou, A., Mavrikiou, E., Ormiston, A. & Kyriakides, T. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy. Hum. Mol. Genet. 15, 1623–1628 (2006).
Google Scholar
Masubuchi, N., Shidoh, Y., Kondo, S., Takatoh, J. & Hanaoka, K. Subcellular localization of dystrophin isoforms in cardiomyocytes and phenotypic analysis of dystrophin-deficient mice reveal cardiac myopathy is predominantly caused by a deficiency in full-length dystrophin. Exp Anim. 62, 211–217 (2013).
Google Scholar
Ma, Z. et al. PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components. Nature 568, 259–263 (2019).
Google Scholar
Serobyan, V. et al. Transcriptional adaptation in Caenorhabditis elegans. eLife 9, e50014 (2020).
Google Scholar
Kontarakis, Z. & Stainier, D. Y. R. Genetics in light of transcriptional adaptation. Trends Genet. 36, 926–935 (2020).
Google Scholar
Sztal, T. E. & Stainier, D. Y. R. Transcriptional adaptation: a mechanism underlying genetic robustness. Development 147, dev186452 (2020).
Google Scholar
Jakutis, G. & Stainier, D. Y. R. Genotype–phenotype relationships in the context of transcriptional adaptation and genetic robustness. Annu. Rev. Genet. 55, 71–91 (2021).
Google Scholar
Jiang, Z. et al. Parental mutations influence wild-type offspring via transcriptional adaptation. Sci. Adv. 8, eabj2029 (2022).
Google Scholar
Fernandez-Abascal, J., Wang, L., Graziano, B., Johnson, C. K. & Bianchi, L. Exon dependent transcriptional adaptation by exon-junction complex proteins Y14/RNP-4 and MAGOH/MAG-1 in Caenorhabditis elegans. PLoS Genet. 18, e1010488 (2022).
Google Scholar
Welker, J. M., Serobyan, V., Esfahani, E. Z. & Stainier, D. Y. R. Partial sequence identity in a 25-nucleotide long element is sufficient for transcriptional adaptation in the Caenorhabditis elegans act-5/act-3 model. PLoS Genet. 19, e1010806 (2023).
Google Scholar
Tuffery-Giraud, S. et al. Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum. Mutat. 30, 934–945 (2009).
Google Scholar
Juan-Mateu, J. et al. Interplay between DMD point mutations and splicing signals in dystrophinopathy phenotypes. PLoS ONE 8, e59916 (2013).
Google Scholar
Flanigan, K. M. et al. Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum. Mutat. 32, 299–308 (2011).
Google Scholar
Boireau, S. et al. The transcriptional cycle of HIV-1 in real-time and live cells. J. Cell Biol. 179, 291–304 (2007).
Google Scholar
Darzacq, X. et al. In vivo dynamics of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 14, 796–806 (2007).
Google Scholar
Dujardin, G. et al. How slow RNA polymerase II elongation favors alternative exon skipping. Mol. Cell 54, 683–690 (2014).
Google Scholar
Listerman, I., Sapra, A. K. & Neugebauer, K. M. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat. Struct. Mol. Biol. 13, 815–822 (2006).
Google Scholar
Marasco, L. E. et al. Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy. Cell 185, 2057–2070 (2022).
Google Scholar
Lalonde, S. et al. Frameshift indels introduced by genome editing can lead to in-frame exon skipping. PLoS ONE 12, e0178700 (2017).
Google Scholar
Anderson, J. L. et al. mRNA processing in mutant zebrafish lines generated by chemical and CRISPR-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay. PLoS Genet. 13, e1007105 (2017).
Google Scholar
Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. & Krainer, A. R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568–3571 (2003).
Google Scholar
Maquat, L. E. Nonsense-mediated mRNA decay in mammals. J. Cell Sci. 118, 1773–1776 (2005).
Google Scholar
Monaghan, L., Longman, D. & Cáceres, J. F. Translation-coupled mRNA quality control mechanisms. EMBO J. 42, e114378 (2023).
Google Scholar
McCarthy, J. J., Esser, K. A. & Andrade, F. H. MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am. J. Physiol. Cell Physiol. 293, C451–C457 (2007).
Google Scholar
Verhaart, I. E. et al. The dynamics of compound, transcript, and protein effects after treatment with 2OMePS antisense oligonucleotides in mdx mice. Mol. Ther. Nucleic Acids 3, e148 (2014).
Google Scholar
Dhoke, N. R. et al. A novel CRISPR–Cas9 strategy to target DYSTROPHIN mutations downstream of exon 44 in patient-specific DMD iPSCs. Cells 13, 972 (2024).
Google Scholar
Zhong, G. et al. A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo. Nat. Biotechnol. 38, 169–175 (2020).
Google Scholar
Doherty, E. A. & Doudna, J. A. Ribozyme structures and mechanisms. Annu. Rev. Biochem. 69, 597–615 (2000).
Google Scholar
Arechavala-Gomeza, V. et al. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum. Gene Ther. 18, 798–810 (2007).
Google Scholar
Galli, F. et al. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne muscular dystrophy. EMBO Mol. Med. https://doi.org/10.1038/s44321-024-00031-3 (2024).
Tinsley, J. M. et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349–353 (1996).
Google Scholar
Sengupta, K., Loro, E. & Khurana, T. S. PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD). Sci. Rep. 10, 21492 (2020).
Google Scholar
Carlice-Dos-Reis, T. et al. Investigation of mutations in the HBB gene using the 1,000 genomes database. PLoS ONE 12, e0174637 (2017).
Google Scholar
Kelly, M. A. et al. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel. Genet. Med. 20, 351–359 (2018).
Google Scholar
Dietz, H. C. et al. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 17, 468–475 (1993).
Google Scholar
Marasco, L. E. & Kornblihtt, A. R. The physiology of alternative splicing. Nat. Rev. Mol. Cell Biol. 24, 242–254 (2022).
Google Scholar
Mikutis, S. et al. Proximity-induced nucleic acid degrader (PINAD) approach to targeted RNA degradation using small molecules. ACS Cent. Sci. 9, 892–904 (2023).
Google Scholar
Farruggio, A. P. et al. Genomic integration of the full-length dystrophin coding sequence in Duchenne muscular dystrophy induced pluripotent stem cells. Biotechnol. J. https://doi.org/10.1002/biot.201600477 (2017).
Kowarz, E. et al. Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines. Biotechnol. J. 10, 647–653 (2015).
Google Scholar
García-Nafría, J., Watson, J. F. & Greger, I. H. IVA cloning: a single-tube universal cloning system exploiting bacterial in vivo assembly. Sci. Rep. 6, 27459 (2016).
Google Scholar
Bouyahya, A. et al. Pharmacological properties of trichostatin A, focusing on the anticancer potential: a comprehensive review. Pharmaceuticals 15, 1235 (2022).
Google Scholar
Veloso, A. et al. Genome-wide transcriptional effects of the anti-cancer agent camptothecin. PLoS ONE 8, e78190 (2013).
Google Scholar
Mamchaoui, K. et al. Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet. Muscle 1, 34 (2011).
Google Scholar
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protocols 8, 2281–2308 (2013).
Google Scholar
Mandric, I. et al. Fast bootstrapping-based estimation of confidence intervals of expression levels and differential expression from RNA-seq data. Bioinformatics 33, 3302–3304 (2017).
Google Scholar
